CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Inogen outlines $355M-$361M 2026 revenue while targeting about $4M adjusted EBITDA amid U.S. channel mix pressure

EarningsNegative
AI Analysis

Summary

Inogen provided 2026 revenue guidance of $355M-$361M with targeted adjusted EBITDA of approximately $4M, citing U.S. channel mix pressure as a headwind.

Financial Highlights

Revenue

$355M-$361M

Guidance

2026 revenue guidance of $355M-$361M with approximately $4M adjusted EBITDA

Importance:3/10
Sentiment:
-0.30
guidancerevenueEBITDAchannel mix pressureU.S. market
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 7, 2026 2:25 PM

Read Original